F-18-fluorodeoxyglucose positron emission tomography imaging-assisted management of patients with severe left ventricular dysfunction and suspected coronary disease: a randomized, controlled trial (PARR-2).
Explore this paper's citation graph
Summary
This study did not demonstrate a significant reduction in cardiac events in patients with LV dysfunction and suspected coronary disease for FDG PET-assisted management versus standard care, but in those who adhered to PET recommendations and in patients without recent angiography, significant benefits were observed.
- Type
- article
- Published
- 2007-11-13
- Cited by
- 461
- References
- 37
- OpenAlex
- https://openalex.org/W2516648
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:33825776
Keywords
Medicine, Revascularization, Hazard ratio, Myocardial infarction, Fluorodeoxyglucose
References
- Is it time for a randomized trial of surgical treatment of ischemic heart failure?
- Improving imaging: our professional imperative.
- Myocardial glucose utilization and optimization of (18)F-FDG PET imaging in patients with non-insulin-dependent diabetes mellitus, coronary artery disease, and left ventricular dysfunction.
- Prediction of Reversible Myocardial Dysfunction by Positron Emission Tomography, Low-Dose Dobutamine Echocardiography, Resting ECG, and Exercise Testing
- Myocardial Viability Testing and the Effect of Early Intervention in Patients With Advanced Left Ventricular Systolic Dysfunction
- Coronary Revascularization Rather than Cardiac Transplantation for Chronic Ischemic Cardiomyopathy
- Comparison of sestamibi, thallium, echocardiography and PET for the detection of hibernating myocardium
- Prognosis of Patients With Left Ventricular Dysfunction, With and Without Viable Myocardium After Myocardial Infarction: Relative Efficacy of Medical Therapy and Revascularization
- Pet myocardial perfusion and glucose metabolism imaging: Part 2-guidelines for interpretation and reporting
- Preoperative comparison of different noninvasive strategies for predicting improvement in left ventricular function after coronary artery bypass grafting.
- Revascularization and ventricular restoration in patients with ischemic heart failure: the STICH trial
- Positron emission tomography and recovery following revascularization (PARR-1): the importance of scar and the development of a prediction rule for the degree of recovery of left ventricular function.
- Is the prognosis of heart failure improving?
- CCS/CAR/CANM/CNCS/CanSCMR joint position statement on advanced noninvasive cardiac imaging using positron emission tomography, magnetic resonance imaging and multidetector computed tomographic angiography in the diagnosis and evaluation of ischemic heart disease--executive summary.
- The effect of cardiac resynchronization on morbidity and mortality in heart failure.
- Evaluation of outcome and cost-effectiveness using an FDG PET-guided approach to management of patients with coronary disease and severe left ventricular dysfunction (PARR-2): rationale, design, and methods.
- Clinical outcome of patients with advanced coronary artery disease after viability studies with positron emission tomography.
- The bad ventricle--revascularization versus transplantation.
- Nephrogenic systemic fibrosis: risk factors and incidence estimation.
- A multiple testing procedure for clinical trials.
Cited by
- Cardiac imaging modalities with ionizing radiation: the role of informed consent.
- Impact of CT attenuation correction on the viability pattern assessed by 99mTc-tetrofosmin SPECT/18F-FDG PET
- Positron emission tomography for the evaluation and treatment of cardiomyopathy
- Looking for Myocardial Viability After a STICH Trial: Not Enough to Close the Door
- ASNC imaging guidelines/SNMMI procedure standard for positron emission tomography (PET) nuclear cardiology procedures
- Recent Advances in Nuclear Cardiology
- Nuclear cardiology for a cardiothoracic surgeon
- Increasing benefit from revascularization is associated with increasing amounts of myocardial hibernation: a substudy of the PARR-2 trial.
- AUTOLOGOUS BONE MARROW MONONUCLEAR CELL TRANSPLANTATION AND CORONARY BYPASS SURGERY FOR TREATMENT OF ISCHEMIC HEART FAILURE
- Cardiac applications of PET
- Técnicas não invasivas de imagem cardíaca na avaliação da doença coronária crónica :aplicações actuais e perspectiva futura
- Ischaemic vs non-ischaemic dilated cardiomyopathy: The value of nuclear cardiology techniques
- Diagnostic Value of Nuclear Cardiology in Coronary Artery Disease
- Patient management after noninvasive cardiac imaging results from SPARC (Study of myocardial perfusion and coronary anatomy imaging roles in coronary artery disease).
- PET and PET/CT in cardiovascular disease
- Revascularization in Severe Left Ventricular Dysfunction: Does Myocardial Viability Even Matter?
- Diagnostic value of 18F-FDG PET in the assessment of myocardial viability in coronary artery disease: A comparative study with 99mTc SPECT and echocardiography
- Value of Hybrid Imaging with PET/CT to Guide Percutaneous Revascularization of Chronic Total Coronary Occlusion
- [Benefit assessment of PET in malignant lymphomas. The IQWiG point of view].
- Viability assessment after conventional coronary angiography using a novel cardiovascular interventional therapeutic CT system: Comparison with gross morphology in a subacute infarct swine model
Related papers
- Positron emission tomography in gastric and esophageal cancer
- Review of clinical practice utility of positron emission tomography with 18F-fluorodeoxyglucose in assessing tumour response to therapy
- Tumor-Specific Positron Emission Tomography Imaging in Patients: [18F] Fluorodeoxyglucose and Beyond
- Post-Surgical Atypical FDG-PET Uptake
- Regional Brain Glucose Utilization in Adenylosuccinase-Deficient Patients Measured by Positron Emission Tomography
- Diagnostic utility of positron emission tomography-computed tomography and indications for 18F-Fluorodeoxyglucose and amyloid-tracers
- Role of functional imaging in head and neck squamous cell carcinoma: fluorodeoxyglucose positron emission tomography and beyond.
- Fluorodeoxyglucose positron emission tomography in the presence of cardiac metastases.